Literature DB >> 32112485

EP3 signaling in dendritic cells promotes liver repair by inducing IL-13-mediated macrophage differentiation in mice.

Shuji Nakamoto1,2,3, Yoshiya Ito1,2, Nobuyuki Nishizawa2,3, Takuya Goto1,2,3, Ken Kojo3, Yusuke Kumamoto3, Masahiko Watanabe3, Shuh Narumiya4, Masataka Majima1,2.   

Abstract

Macrophage plasticity is essential for liver wound healing; however, the mechanisms underlying macrophage phenotype switching are largely unknown. Dendritic cells (DCs) are critical initiators of innate immune responses; as such, they orchestrate inflammation following hepatic injury. Here, we subjected EP3-deficient (Ptger3-/- ) and wild-type (WT) mice to hepatic ischemia-reperfusion (I/R) and demonstrate that signaling via the prostaglandin E (PGE) receptor EP3 in DCs regulates macrophage plasticity during liver repair. Compared with WT mice, Ptger3-/- mice showed delayed liver repair accompanied by reduced expression of hepatic growth factors and accumulation of Ly6Clow reparative macrophages and monocyte-derived DCs (moDCs). MoDCs were recruited to the boundary between damaged and undamaged liver tissue in an EP3-dependent manner. Adoptive transfer of moDCs from Ptger3-/- mice resulted in impaired repair, along with increased numbers of Ly6Chigh inflammatory macrophages. Bone marrow macrophages (BMMs) up-regulated expression of genes related to a reparative macrophage phenotype when co-cultured with moDCs; this phenomenon was dependent on EP3 signaling. In the presence of an EP3 agonist, interleukin (IL)-13 derived from moDCs drove BMMs to increase expression of genes characteristic of a reparative macrophage phenotype. The results suggest that EP3 signaling in moDCs facilitates liver repair by inducing IL-13-mediated switching of macrophage phenotype from pro-inflammatory to pro-reparative.
© 2020 Federation of American Societies for Experimental Biology.

Entities:  

Keywords:  crosstalk; immune cells; ischemia; prostaglandin; reperfusion

Year:  2020        PMID: 32112485     DOI: 10.1096/fj.201901955R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  6 in total

1.  EP3 enhances adhesion and cytotoxicity of NK cells toward hepatic stellate cells in a murine liver fibrosis model.

Authors:  Xixi Tao; Rui Zhang; Ronglu Du; Tingting Yu; Hui Yang; Jiwen Li; Yuhong Wang; Qian Liu; Shengkai Zuo; Xi Wang; Michael Lazarus; Lu Zhou; Bangmao Wang; Ying Yu; Yujun Shen
Journal:  J Exp Med       Date:  2022-04-14       Impact factor: 14.307

2.  Macrophages contribute to liver repair after monocrotaline-induced liver injury via SDF-1/CXCR4.

Authors:  Fumisato Otaka; Yoshiya Ito; Shuji Nakamoto; Nobuyuki Nishizawa; Tetsuya Hyodo; Kanako Hosono; Masataka Majima; Wasaburo Koizumi; Hideki Amano
Journal:  Exp Ther Med       Date:  2021-04-22       Impact factor: 2.447

3.  Breast adipose tissue macrophages (BATMs) have a stronger correlation with breast cancer survival than breast tumor stroma macrophages (BTSMs).

Authors:  Lili Lin; Christina Kuhn; Nina Ditsch; Thomas Kolben; Bastian Czogalla; Susanne Beyer; Fabian Trillsch; Elisa Schmoeckel; Doris Mayr; Sven Mahner; Udo Jeschke; Anna Hester
Journal:  Breast Cancer Res       Date:  2021-04-13       Impact factor: 6.466

4.  Ablation of Cbl-b and c-Cbl in dendritic cells causes spontaneous liver cirrhosis via altering multiple properties of CD103+ cDC1s.

Authors:  Fei Xu; Chen Liu; Yongli Dong; Wenyan Wu; Jie Xu; Yunqiu Yan; Yu Shao; Chuangli Hao; Yi Yang; Jinping Zhang
Journal:  Cell Death Discov       Date:  2022-03-30

5.  Activation of iNKT Cells Facilitates Liver Repair After Hepatic Ischemia Reperfusion Injury Through Acceleration of Macrophage Polarization.

Authors:  Takuya Goto; Yoshiya Ito; Masashi Satoh; Shuji Nakamoto; Nobuyuki Nishizawa; Kanako Hosono; Takeshi Naitoh; Koji Eshima; Kazuya Iwabuchi; Naoki Hiki; Hideki Amano
Journal:  Front Immunol       Date:  2021-10-06       Impact factor: 7.561

Review 6.  Dendritic Cell-Mediated Regulation of Liver Ischemia-Reperfusion Injury and Liver Transplant Rejection.

Authors:  Ryosuke Nakano; Lillian M Tran; David A Geller; Camila Macedo; Diana M Metes; Angus W Thomson
Journal:  Front Immunol       Date:  2021-06-28       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.